|
[1]
|
Van Gerwen OT, Muzny CA, Marrazzo JM. Sexually transmitted infections and female reproductive health. Nat Microbiol 2022;7(8):1116 − 26. https://doi.org/10.1038/s41564-022-01177-xCrossRef
|
|
[2]
|
Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ 2019;97(8):548 − 62P. https://doi.org/10.2471/BLT.18.228486CrossRef
|
|
[3]
|
Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet 2013;382(9895):889 − 99. https://doi.org/10.1016/S0140-6736(13)60022-7CrossRef
|
|
[4]
|
Akbari E, Milani A, Seyedinkhorasani M, Bolhassani A. HPV co-infections with other pathogens in cancer development: a comprehensive review. J Med Virol 2023;95(11):e29236. https://doi.org/10.1002/jmv.29236CrossRef
|
|
[5]
|
Ye H, Song TG, Zeng X, Li L, Hou MM, Xi MR. Association between genital mycoplasmas infection and human papillomavirus infection, abnormal cervical cytopathology, and cervical cancer: a systematic review and meta-analysis. Arch Gynecol Obstet 2018;297(6):1377 − 87. https://doi.org/10.1007/s00404-018-4733-5CrossRef
|
|
[6]
|
Bahena-Román M, Sánchez-Alemán MA, Contreras-Ochoa CO, Lagunas-Martínez A, Olamendi-Portugal M, López-Estrada G, et al. Prevalence of active infection by herpes simplex virus type 2 in patients with high-risk human papillomavirus infection: a cross-sectional study. J Med Virol 2020;92(8):1246 − 52. https://doi.org/10.1002/jmv.25668CrossRef
|
|
[7]
|
Lu Z, Zhao PZ, Lu HJ, Xiao MF. Analyses of human papillomavirus, Chlamydia trachomatis, Ureaplasma urealyticum, Neisseria gonorrhoeae, and co-infections in a gynecology outpatient clinic in Haikou area, China. BMC Women’s Health 2023;23(1):117. https://doi.org/10.1186/s12905-023-02259-6CrossRef
|
|
[8]
|
Zhong CY, Li XZ, Teng Y, Tian JY. Co-infection with human papillomavirus and sexually transmitted infections among Chinese individuals. Microb Pathog 2023;185:106395. https://doi.org/10.1016/j.micpath.2023.106395CrossRef
|
|
[9]
|
Adebamowo SN, Ma B, Zella D, Famooto A, Ravel J, Adebamowo C, et al. Mycoplasma hominis and Mycoplasma genitalium in the vaginal microbiota and persistent high-risk human papillomavirus infection. Front Public Health 2017;5:140. https://doi.org/10.3389/fpubh.2017.00140CrossRef
|
|
[10]
|
Wang LH. Accelerating cervical cancer prevention and control in China to achieve cervical cancer elimination strategy objectives. China CDC Wkly 2022;4(48):1067 − 9. https://doi.org/10.46234/ccdcw2022.215CrossRef
|